Ocugen RPDD Stargardt
May 28, 2025

FDA Grants Rare Pediatric Disease Designation to Ocugen’s Gene Therapy for Stargardt Disease

Ocugen’s OCU410ST gene therapy lands a rare badge of honor in the fight against IRDs. The U.S. Food and Drug…

Thumbnail Article Bayer EYLEA HD news updates
May 26, 2025

Bayer Notches Dual EYLEA 8mg Wins With China nAMD Approval and EU 6-Month Interval Extension

High-dose aflibercept secured a regulatory victory in China as 6-month dosing nears European approval Good news apparently comes in twos…

Discover our fascinating content at issuu

explore